SCD: FedEx, UPS’ 2025 fee hikes will wallop bulky package shippers
SUPPLY CHAIN DIVE reports: It’s a tough time to be a heavy package shipper. With rate and ...
CHRW: RUNNING HIGHMAERSK: STRONG HON: BREAK-UP APPEALCHRW: CLOSING QUESTIONSCHRW: HEADCOUNT RISK MID-TERM CHRW: SHOOTING UPCHRW: OPPORTUNISTIC CHRW: CFO REMARKSCHRW: GETTING THERE CHRW: SEEKING VALUABLE INSIGHTCHRW: 'FIT FAST AND FOCUSED' CHRW: INVESTOR DAY AMZN: NASDAQ RALLYKNIN: LOOKING DOWNPLD: FLIPPING ASSETSWTC: BOLT-ON DEAL
CHRW: RUNNING HIGHMAERSK: STRONG HON: BREAK-UP APPEALCHRW: CLOSING QUESTIONSCHRW: HEADCOUNT RISK MID-TERM CHRW: SHOOTING UPCHRW: OPPORTUNISTIC CHRW: CFO REMARKSCHRW: GETTING THERE CHRW: SEEKING VALUABLE INSIGHTCHRW: 'FIT FAST AND FOCUSED' CHRW: INVESTOR DAY AMZN: NASDAQ RALLYKNIN: LOOKING DOWNPLD: FLIPPING ASSETSWTC: BOLT-ON DEAL
It would be a more sensational story if it involved illicit drugs smuggled by South American cartels and sold in the deprived and depraved inner cities of the US and Europe, but, alas no.
The world’s largest express provider is under investigation for transporting illegal medical drugs to users who bought online. And it is claimed it was no innocent mistake. Prosecutors allege that over a 10-year period, the company earned almost $1bn and put into place special corporate measures “that would prevent its employees being penalised if a pharmacy abruptly closed for business”.
Comment on this article